Myasthenia gravis market to reach $13.0bn across 7MM by 2034

Neutral

AI Analysis

Summary

The myasthenia gravis market across the 7MM is projected to grow at an 11.1% CAGR from $4.5bn in 2024 to $13.0bn in 2034. This is a market forecast analysis with no company, drug, or catalyst-specific information.

Financial Highlights

Revenue

$13.0bn by 2034

Guidance

CAGR of 11.1% from $4.5bn in 2024 to $13.0bn in 2034

Importance:2/10

Sentiment:

0.00

myasthenia gravismarket analysis7MMforecast

Read the original article

Published by Pharmaceutical Technology on August 28, 2026 3:36 PM

Read Original